These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 9503860)
21. Neuroactive steroid actions at the GABAA receptor. Lan NC; Gee KW Horm Behav; 1994 Dec; 28(4):537-44. PubMed ID: 7729823 [TBL] [Abstract][Full Text] [Related]
22. The role of central glycine receptors in the pharmacologic actions of benzodiazepines. Snyder SH; Enna SJ Adv Biochem Psychopharmacol; 1975; (14):81-91. PubMed ID: 242204 [No Abstract] [Full Text] [Related]
23. Comparison of benzodiazepines and the non-benzodiazepine agents zolpidem and zaleplon with respect to anxiolytic action as measured by increases in hypertonic NaCl-solution drinking in rats. Lobarinas E; Falk JL Psychopharmacology (Berl); 2000 Apr; 149(2):176-80. PubMed ID: 10805613 [TBL] [Abstract][Full Text] [Related]
24. [Possibilities for the classification and differentiation of benzodiazepines]. Laux G Fortschr Med; 1982 Dec; 100(46):2179-80, 2182-6. PubMed ID: 6130035 [No Abstract] [Full Text] [Related]
25. Benzodiazepine actions mediated by specific gamma-aminobutyric acid(A) receptor subtypes. Rudolph U; Crestani F; Benke D; Brünig I; Benson JA; Fritschy JM; Martin JR; Bluethmann H; Möhler H Nature; 1999 Oct; 401(6755):796-800. PubMed ID: 10548105 [TBL] [Abstract][Full Text] [Related]
26. The classification of benzodiazepine hypnotics. Pierce DM; Franklin RA Br J Clin Pharmacol; 1983 Sep; 16(3):345-7. PubMed ID: 6138057 [No Abstract] [Full Text] [Related]
27. [Novel insomnia drugs, including drugs currently under development]. Inada K Nihon Rinsho; 2009 Aug; 67(8):1590-4. PubMed ID: 19768946 [TBL] [Abstract][Full Text] [Related]
28. U-90042, a sedative/hypnotic compound that interacts differentially with the GABAA receptor subtypes. Tang AH; Smith MW; Carter DB; Im WB; VonVoigtlander PF J Pharmacol Exp Ther; 1995 Nov; 275(2):761-7. PubMed ID: 7473164 [TBL] [Abstract][Full Text] [Related]
29. "Peripheral" benzodiazepine recognition sites may be involved in the rapid tolerance to the sedative effects of benzodiazepines in rats. Ambrosio C; De Luca C; Massotti M Adv Biochem Psychopharmacol; 1992; 47():223-7. PubMed ID: 1354916 [No Abstract] [Full Text] [Related]
30. Benzodiazepine, barbiturate, ethanol and hypnotic steroid hormone modulation of GABA-mediated chloride ion transport in rat brain synaptoneurosomes. Morrow AL; Suzdak PD; Paul SM Adv Biochem Psychopharmacol; 1988; 45():247-61. PubMed ID: 2902744 [No Abstract] [Full Text] [Related]
31. Potency of positive gamma-aminobutyric acid(A) modulators to substitute for a midazolam discriminative stimulus in untreated monkeys does not predict potency to attenuate a flumazenil discriminative stimulus in diazepam-treated monkeys. McMahon LR; Gerak LR; France CP J Pharmacol Exp Ther; 2001 Sep; 298(3):1227-35. PubMed ID: 11504825 [TBL] [Abstract][Full Text] [Related]
32. Type A gamma-aminobutyric acid (GABAA) receptor subunits and benzodiazepine binding: significance to clinical syndromes and their treatment. Smith TA Br J Biomed Sci; 2001; 58(2):111-21. PubMed ID: 11440203 [TBL] [Abstract][Full Text] [Related]
33. Discriminative stimulus effects of zolpidem in squirrel monkeys: comparison with conventional benzodiazepines and sedative-hypnotics. Rowlett JK; Spealman RD; Lelas S J Pharmacol Exp Ther; 1999 Dec; 291(3):1233-41. PubMed ID: 10565847 [TBL] [Abstract][Full Text] [Related]
34. Determinants of pharmacologic effects and toxicity of benzodiazepine hypnotics: role of lipophilicity and plasma elimination rates. Arnold J J Clin Psychiatry; 1991 Sep; 52 Suppl():11-4. PubMed ID: 1654317 [TBL] [Abstract][Full Text] [Related]
35. GABA-benzodiazepine receptor complex and drug actions. Saano V Med Biol; 1987; 65(2-3):167-73. PubMed ID: 2888932 [TBL] [Abstract][Full Text] [Related]
36. Zolpidem, a novel nonbenzodiazepine hypnotic. I. Neuropharmacological and behavioral effects. Depoortere H; Zivkovic B; Lloyd KG; Sanger DJ; Perrault G; Langer SZ; Bartholini G J Pharmacol Exp Ther; 1986 May; 237(2):649-58. PubMed ID: 2871178 [TBL] [Abstract][Full Text] [Related]
37. Benzodiazepine receptor binding of benzodiazepine hypnotics: receptor and ligand specificity. Miller LG; Galpern WR; Byrnes JJ; Greenblatt DJ Pharmacol Biochem Behav; 1992 Oct; 43(2):413-6. PubMed ID: 1359574 [TBL] [Abstract][Full Text] [Related]
38. Antagonists of benzodiazepines: functional aspects. Haefely W Adv Biochem Psychopharmacol; 1983; 38():73-93. PubMed ID: 6142609 [TBL] [Abstract][Full Text] [Related]
39. Enhancement of GABAergic inhibition: a mechanism of action of benzodiazepines, phenobarbital, valproate and L-cycloserine in the cat spinal cord. Polc P Electroencephalogr Clin Neurophysiol Suppl; 1982; 36():188-98. PubMed ID: 6130936 [TBL] [Abstract][Full Text] [Related]
40. Native gamma-aminobutyric acid type A receptors from rat hippocampus, containing both alpha 1 and alpha 5 subunits, exhibit a single benzodiazepine binding site with alpha 5 pharmacological properties. Araujo F; Ruano D; Vitorica J J Pharmacol Exp Ther; 1999 Sep; 290(3):989-97. PubMed ID: 10454469 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]